382 related articles for article (PubMed ID: 8370919)
1. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.
Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; Gorman CA
J Endocrinol Invest; 1993 Jun; 16(6):433-7. PubMed ID: 8370919
[TBL] [Abstract][Full Text] [Related]
2. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
[TBL] [Abstract][Full Text] [Related]
3. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases.
Fatourechi V; Pajouhi M; Fransway AF
Medicine (Baltimore); 1994 Jan; 73(1):1-7. PubMed ID: 8309359
[TBL] [Abstract][Full Text] [Related]
4. Pretibial myxedema: pathophysiology and treatment options.
Fatourechi V
Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
[TBL] [Abstract][Full Text] [Related]
5. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease.
Anderson CK; Miller OF
J Am Acad Dermatol; 2003 Jun; 48(6):970-2. PubMed ID: 12789197
[TBL] [Abstract][Full Text] [Related]
6. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
Lohiya S; Lohiya V; Stahl EJ
Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
[TBL] [Abstract][Full Text] [Related]
7. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
Khalilzadeh O; Mojazi Amiri H; Tahvildari M; Anvari M; Esteghamati A; Mobarra Z; Tehranchinia Z; Rashidi A; Amirzargar A
Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
[TBL] [Abstract][Full Text] [Related]
8. Graves ophthalmopathy. Results of transantral orbital decompression performed primarily for cosmetic indications.
Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; DeSanto LW; Gorman CA
Ophthalmology; 1994 May; 101(5):938-42. PubMed ID: 8190484
[TBL] [Abstract][Full Text] [Related]
9. Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution.
Omohundro C; Dijkstra JW; Camisa C; Bergfeld WF
Cutis; 1996 Sep; 58(3):211-4. PubMed ID: 8886536
[TBL] [Abstract][Full Text] [Related]
10. Exophthalmos, pretibial myxedema, osteoarthropathy syndrome associated with papillary fibroelastoma in the left ventricle.
Suzuki H; Shimura H; Haraguchi K; Harii N; Endo T; Hosaka S; Yoshii S; Tada Y; Onaya T
Thyroid; 1999 Dec; 9(12):1257-60. PubMed ID: 10646668
[TBL] [Abstract][Full Text] [Related]
11. Pretibial myxedema with Graves' disease: a case report and review of Japanese literature.
Ishizawa T; Sugiki H; Anzai S; Kondo S
J Dermatol; 1998 Apr; 25(4):264-8. PubMed ID: 9609987
[TBL] [Abstract][Full Text] [Related]
12. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic orbital decompression for Graves' ophthalmopathy.
Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
[TBL] [Abstract][Full Text] [Related]
15. [Pretibial myxedema after Graves' disease: A differential diagnosis of lymphedema].
Lebreton O; Seddiki R; Abba S; Vignes S
Rev Med Interne; 2023 Dec; 44(12):641-645. PubMed ID: 37827928
[TBL] [Abstract][Full Text] [Related]
16. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.
Kuzuya N; DeGroot LJ
J Endocrinol Invest; 1982; 5(6):373-8. PubMed ID: 6132943
[TBL] [Abstract][Full Text] [Related]
17. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.
Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M
Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966
[TBL] [Abstract][Full Text] [Related]
18. Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
Antonelli A; Navarranne A; Palla R; Alberti B; Saracino A; Mestre C; Roger P; Agostini S; Baschieri L
Thyroid; 1994; 4(4):399-408. PubMed ID: 7711502
[TBL] [Abstract][Full Text] [Related]
19. [A rare hyperthyroid syndrome].
Artuso V; Roiter I
Minerva Endocrinol; 2004 Jun; 29(2):71-5. PubMed ID: 15257258
[TBL] [Abstract][Full Text] [Related]
20. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.
Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ
Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
